Stockscreener 앱 받기
15.76
5.14%
0.77
시간 외 거래:
15.80
0.04
+0.25%
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
Will Avadel Pharmaceuticals plc continue its uptrendStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - Newser
What is the earnings history of Avadel Pharmaceuticals plc2025 Key Lessons & Detailed Earnings Play Strategies - خودرو بانک
Smart tools for monitoring Avadel Pharmaceuticals plc’s price actionQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersCEO Change & Daily Profit Maximizing Tips - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsPortfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Avadel Pharmaceuticals at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com UK
Avadel Pharmaceuticals Presents 17 Abstracts on LUMRYZ Efficacy at World Sleep 2025, Highlighting Benefits of Once-Nightly Sodium Oxybate for Narcolepsy Treatment - Quiver Quantitative
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - The Manila Times
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - GlobeNewswire Inc.
Predicting Avadel Pharmaceuticals plc trend using moving averagesJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Is Avadel Pharmaceuticals plc stock ready for a breakout2025 Market Outlook & Reliable Breakout Forecasts - Newser
Applying Elliott Wave Theory to Avadel Pharmaceuticals plcJobs Report & High Accuracy Swing Entry Alerts - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityWeekly Volume Report & Daily Price Action Insights - Newser
Published on: 2025-09-04 22:28:10 - Newser
The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review
Avadel Pharmaceuticals plc Testing Reversal Zone on Weekly ChartDividend Hike & Free Fast Entry Momentum Trade Alerts - beatles.ru
Avadel Pharmaceuticals (AVDL) Attracts Institutional Investment - MSN
Why Avadel Pharmaceuticals plc is moving todayJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Avadel secures rights to develop valiloxybate globally - Pharmaceutical Technology
Sleep Disorder Market Heats Up with Avadel’s Global Grab for Valiloxybate - geneonline.com
Avadel licenses once-at-bedtime oxybate therapy from XWPharma By Investing.com - Investing.com Canada
Will Avadel Pharmaceuticals plc rebound enough to break evenJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Can you recover from losses in Avadel Pharmaceuticals plcWeekly Loss Report & Low Drawdown Investment Ideas - Newser
How to read the order book for Avadel Pharmaceuticals plcTrade Risk Report & Weekly Sector Rotation Insights - Newser
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com
Avadel: XWPharma to receive $20m upfront - AInvest
Avadel Pharmaceuticals gets Valiloxybate license from XWPharma - AInvest
Avadel Pharmaceuticals Licenses Valiloxybate from XWPharma for Sleep Treatments. - AInvest
Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd - The Manila Times
Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan
Is Avadel Pharmaceuticals plc currently under institutional pressureJuly 2025 Recap & Reliable Breakout Stock Forecasts - خودرو بانک
Wells Fargo Initiates Avadel Pharmaceuticals at Equalweight With $16 Price Target - MarketScreener
Is now a turning point for Avadel Pharmaceuticals plcMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
Avadel Pharmaceuticals plc stock chart pattern explained2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Sector ETF performance correlation with Avadel Pharmaceuticals plcWeekly Volume Report & Weekly High Conviction Ideas - Newser
Can Avadel Pharmaceuticals plc continue delivering strong returnsForecast Cut & Smart Investment Allocation Insights - خودرو بانک
Custom watchlist performance reports with Avadel Pharmaceuticals plcJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Will Avadel Pharmaceuticals plc outperform the marketPortfolio Gains Summary & Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Avadel Pharmaceuticals plcJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Is now the right time to enter Avadel Pharmaceuticals plcMarket Volume Summary & Real-Time Market Sentiment Alerts - خودرو بانک
Pullback Watch: Is Avadel Pharmaceuticals plc exposed to political riskMarket Activity Summary & High Return Trade Guides - خودرو بانک
Can Avadel Pharmaceuticals plc benefit from deglobalizationQuarterly Performance Summary & Community Driven Trade Alerts - خودرو بانک
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter - MSN
Is Avadel Pharmaceuticals plc stock good for income investors2025 Macro Impact & Real-Time Chart Breakout Alerts - خودرو بانک
How to use a screener to detect Avadel Pharmaceuticals plc breakoutsWeekly Trade Review & Accurate Intraday Trade Tips - Newser
3.53%
자본화:
|
볼륨(24시간):